COVID-19 bilan kasallangan erkaklar jinsiy faoliyatidagi o‘zgarishlar

Glybochko P.V., Alyaev Yu.G., Markosyan T.G. Modern methods of diagnosing erectile dysfunction. Sechenovskiyvestnik. 2018; 2:43–50.

Glybochko P.V., Alyaev Yu.G., Esilevsky Yu.M. Choice of phosphor diesterase type 5 inhibitors for the treatment of patients with erectile dysfunction and chronic prostatitis. Sechenovskiy vestnik. 2019; 2:33–40.

Glybochko P.V., AlyaevYu.G., EsilevskyYu.M. et al. Results of pharmacodopplerography of cavernous arteries with alprostadil. Medical Bulletin of Bashkortostan. 2020; 8(3): 34-8.

Danilov A.B. Sexual dysfunction. In the book: Autonomic disorders: clinic, treatment, diagnosis / Ed. A.M. Wayne. M.: Medical Information Agency; 1998. 373–90.

Sivkov A.V., Koryakin A.V., Sinyagin A.A., Apolikhin O.I., Kaprin A.D. The genitourinary system and COVID-19: some aspects. Experimental and Clinical Urology2020;(2):18-23.

Bendayan M., Robin G., Hamdi S., Mieusset R., Boitrelle F. COVID-19 in men: With or without virus in semen, spermatogenesis may be impaired// Andrologia2021; 53(1), 226

Gervasi G., Bramanti P., Di Bella P. Clinical and Instrumental diagnosis of sexual disorders. In: Male Sexual Dysfunctions in Neurological Diseases: From Pathophysiology to Rehabilitation/Ed. RSCalabro. New York: Nova Science Publishers, Inc., 2019.

Lue TF erectile dysfunction. N. Engl. J. Med. 20 20 ; 342: 1802–13.

Mc Vary KT Erectile dysfunction. N. Engl. J. Med. 20 18 ; 357:2472–81.

Çayan S., Uğuz M., Saylam B., Akbay E. Effect of serum total testosterone and its relationship with other laboratory parameters on the prognosis of coronavirus disease 2019 (COVID-19) in SARS-CoV-2 infected male patients: a cohort study. // Aging Male 2020; 23(5):1493-1503.

Dutta S., Sengupta P. SARS-CoV-2 and male infertility: possible multifaceted pathology// Reprodsci2021; 28(1): 23–26.

Hackett G., Kirby M. Testosterone deficiency in men infected with COVID-19. //Trends Urology Health, 2020; 11:7-10.

Pozzilli P, Lenzi A. Testosterone, a key hormone in the context of COVID-19 pandemic // Metabolism 2020; 108:152-156.

Rastrelli G. et al. Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients// Andrology2021; 9(1):88–98.

Salonia A, Corona G., Giwercman A. et al. SARS-CoV-2, testosterone and frailty in males (PROTEGGIMI): a multidimensional research project // Andrology, 2021; 9(1): 19-22.

Sansone A., Mollaioli D. et al. Addressing male sexual and reproductive health in the wake of COVID-19 outbreak //J. Endocrinol Invest 2021; 44(2): 223–31.

Schroeder M., Tuku B., Jarczak D. The majority of male patients with COVID-19 present low testosterone levels on admission to intensive care in Hamburg, Germany: a retrospective cohort study//andrology, 2021; 9(1): 118–124.

Selvaraj K. et al. Testicular Atrophy and Hypothalamic Pathology in COVID-19: possibility of the incidence of male infertility and HPG axis abnormalities/ /Reprodsci 2021; Jan 7:1-8.

Younis J S, Abassi Z., Skorecki K. Is there an impact of the COVID-19 pandemic on male fertility? The ACE2 connection// J. Physiol Endocrinol metab. 2020; 318(6):878-880.